IL-17A exacerbates psoriasis in a STAT3 overexpressing mouse model

Area of Science:

• Dermatology
• Immunology
• Genetics

Background:

• Psoriasis is an autoimmune skin disease driven by keratinocyte and immune cell activation.
• Signal transducer and activator of transcription 3 (STAT3) is key in linking these cells during psoriasis.
• T helper 17 (Th17) cells and interleukin-17A (IL-17A) are implicated in psoriasis pathogenesis.

Purpose of the Study:

• To establish and characterize a mouse model of psoriasiform dermatitis.
• To investigate the role of STAT3 and IL-17A in a psoriasis-like phenotype.
• To compare gene expression profiles with human psoriasis.

Main Methods:

• Developed a mouse model by intradermal IL-17A injection into STAT3 overexpressing mice.
• Performed transcriptome analysis on skin tissues from wild-type, STAT3, and IL-17A treated STAT3 mice.
• Analyzed differentially expressed genes (DEGs) and enriched pathways using bioinformatics and qPCR.

Main Results:

• IL-17A treated STAT3 mice exhibited hyperkeratosis and parakeratosis, characteristic of psoriasis.
• DEGs in the mouse model closely mirrored those found in human psoriasis patients (e.g., S100A8, S100A9).
• Gene Ontology and KEGG analyses highlighted immune response, chemotaxis, and IL-17 signaling pathways.

Conclusions:

• IL-17A exacerbates psoriasis dermatitis in a STAT3 overexpressing mouse model.
• This model effectively mimics key pathological and molecular features of human psoriasis.
• The study validates the role of the STAT3-IL-17A axis in psoriasis development.